Chao-Cheng Huang
Overview
Explore the profile of Chao-Cheng Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
205
Citations
2813
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang S, Hu T, Ching-Wu J, Yi L, Kuo H, Kung M, et al.
Lab Invest
. 2025 Mar;
:104127.
PMID: 40081662
Hepatoma-derived growth factor (HDGF) is located on chromosome 1q21-23, a locus frequently amplified in hepatocellular carcinoma (HCC), and has been proposed as an oncogenic factor by stimulating PI3K/Akt signaling. Phosphatase...
2.
Huang Y, Ou Y, Wu C, Lan J, Huang C, Fu H, et al.
J Formos Med Assoc
. 2024 Aug;
PMID: 39183142
Aims: This study aimed to assess the accuracy of a two-protein panel for mismatch repair (MMR) immunohistochemistry (IHC) compared to a four-protein panel in a cohort of endometrial cancer patients....
3.
Wu Z, Kao C, Wang H, Lee W, Luo H, Huang C, et al.
Int Urol Nephrol
. 2024 Jul;
57(1):49-61.
PMID: 39078466
Aims: Low-energy shock waves (LESWs) are known to alter cell-membrane permeability. This study aimed to investigate the effect of LESWs on Escherichia coli and E. coli-induced cystitis in rats. Main...
4.
Wu Z, Lee W, Chancellor M, Wang H, Huang C, Chuang Y
Int J Surg
. 2024 Jul;
110(11):6869-6872.
PMID: 39037744
No abstract available.
5.
Wang C, Fan W, Liu T, Pang S, Wang J, Huang C, et al.
Anticancer Res
. 2023 Sep;
43(10):4709-4722.
PMID: 37772577
Background/aim: The aim of the current study was to obtain comprehensive genomic information on viral hepatitis B (HBV)-related hepatocellular carcinoma (HCC) and identify potential biomarkers of early recurrence in patients...
6.
Chang Y, Huang G, Chen Y, Huang K, Chen Y, Lin C, et al.
BMC Cancer
. 2023 Jun;
23(1):569.
PMID: 37340370
Background: The expression of programmed death-ligand 1 (PD-L1), tumor-infiltrating lymphocytes (TILs), E-cadherin, and vimentin in lung cancer tumor microenvironment is known to impact patient survival or response to therapy. The...
7.
Huang S, Huang C, Ko C, Huang C, Liu C, Lee Y, et al.
Gene
. 2023 Mar;
865:147331.
PMID: 36871674
Slow skeletal muscle troponin T (TNNT1) as a poor prognostic indicator is upregulated in colon and breast cancers. However, the role of TNNT1 in the disease prognosis and biological functions...
8.
Huang G, Huang C, Kang C, Cheng Y, Tsai P, Kao Y, et al.
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36675289
Upper tract urothelial cancer (UTUC) is a less common disease in Western countries but has a high level of prevalence in Asian populations. Compared to bladder cancer, unique etiologic and...
9.
Wu J, Huang C, Wang P, Chen T, Hsu W, Chuang J, et al.
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36675163
Neuroblastoma (NB) is characterized by several malignant phenotypes that are difficult to treat effectively without combination therapy. The therapeutic implication of mitochondrial ClpXP protease ClpP and ClpX has been verified...
10.
Yu S, Hsiao Y, Cooper W, Choi Y, Aviles-Salas A, Chou T, et al.
Pathology
. 2022 Nov;
55(1):19-30.
PMID: 36319485
PD-L1 immunohistochemistry has been approved as a diagnostic assay for immunotherapy. However, an international comparison across multiple cancers is lacking. This study aimed to assess the performance of PD-L1 diagnostic...